Literature DB >> 19282187

Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.

Ana Carolina C Asbahr1, Luzia Franco, Andersson Barison, Caroline W P Silva, Humberto G Ferraz, Letícia N C Rodrigues.   

Abstract

The aim of this study was to determine whether inclusion complexes between 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) and finasteride (FIN) are formed, and to characterize these. Equimolar FIN/HPbetaCD solid systems in the presence or absence of 0.1% (w/v) of polyvinylpyrrolidone K30 (PVP K30) or 0.3% of chitosan were prepared by coevaporation and freeze-drying methods. The systems were characterized by phase solubility, NMR, DSC, and XRD analysis. The results suggest that true binary and ternary inclusion complexes were formed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282187     DOI: 10.1016/j.bmc.2009.02.044

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Interaction of artesunate with β-cyclodextrin: Characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity.

Authors:  Renu Chadha; Sushma Gupta; Geeta Shukla; D V S Jain; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  Results Pharma Sci       Date:  2011-08-04

2.  Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.

Authors:  P A Pacheco; L N C Rodrigues; J F S Ferreira; A C P Gomes; C J Veríssimo; H Louvandini; R L D Costa; L M Katiki
Journal:  Parasitol Res       Date:  2018-01-11       Impact factor: 2.289

3.  An Ilomastat-CD Eye Drop Formulation to Treat Ocular Scarring.

Authors:  Abeer H A Mohamed-Ahmed; Alastair Lockwood; He Li; Maryse Bailly; Peng T Khaw; Steve Brocchini
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-07-01       Impact factor: 4.799

4.  Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.

Authors:  Fatma M Mady; Usama Farghaly Aly
Journal:  Drug Des Devel Ther       Date:  2017-06-07       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.